Crystal structure,electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam = 1,4,8,11-tetraazacyclotetradecane)

The trans-[Fe(cyclam)(NO)Cl]Cl₂ complex was synthesized by the reaction of cis-[Fe(cyclam)Cl₂]Cl with NO gas. The X-ray structure of the complex showed that the [Fe–NO] moiety is linear, consistent with the NO⁺ character of the nitric oxide ligand. This suggestion was reinforced by the IR data, which showed the νNO at 1888 cm⁻¹. The cyclic voltammogram of the trans-[Fe(cyclam)(NO)Cl]²⁺ complex presented three electrochemical processes at −0.70, 0.08 and 0.40 V versus Ag/AgCl. The first and last redox processes are centered at the NO ligand, whereas the second is characteristic of the generated aqua species, trans-[Fe(cyclam)Cl(H₂O)]²⁺. Upon irradiation at 330 nm, pH 3.4, the title complex releases the NO moiety with the concomitant generation of the trans-[Fe(cyclam)(H₂O)Cl]⁺ complex as suggested by electronic and IR spectroscopy as well as by cyclic voltammetry technique.     

Synthesis and Characterization of Novel Trans-Mixed Diamine Platinum(II) and Platinum(IV) Complexes

A series of novel trans-mixed diamine platinum(II) and platinum(IV) complexes of type trans-[Pt^II(R-NH₂)(R'-NH₂)Cl₂] and trans -[Pt^IV(R-NH₂)(R'-NH₂)Cl₄] (where R-NH₂ = ethylamine or butylamine and R'-NH₂ = methylamine, propylamine, isopropylamine, pentylamine, or hexylamine) was synthesized and characterized using elemental analysis and infrared and ¹⁹⁵Pt nuclear magnetic resonance spectroscopic techniques.     

Bis(ferrocenium) bis[tetrachloroantimonate(III)] trichloroantimony(III)

In the title compound, [Fe(C₅H₅)₂]₂[SbCl₄]₂[SbCl₃], the cyclo­penta­dienyl rings in both cations are parallel, with a nearly eclipsed conformation. The Sb³⁺ ions are coordinated by six Cl^? ions to form octahedral arrangements, of which two are slightly distorted. These octahedra form infinite chains along the c axis through Cl—Sb—Cl bridges.     

The HNO donor ability of hydroxamic acids upon oxidation with cyanoferrates(III)

The hydroxamic acids (RC(O)NHOH, HA) exhibit diverse biological activity, including hypotensive properties associated with formation of nitroxyl (HNO) or nitric oxide (NO). Oxidation of two HAs, benzohydroxamic and acetohydroxamic acids (BHA, AHA) by [Fe(CN)₅NH₃]^2? or [Fe(CN)₆]^3? was analyzed by spectroscopic, mass spectrometric techniques, and flow EPR measurements. Mixing BHA with both Fe(III) reactants at pH 11 allowed detecting the hydroxamate radical, (C₆H₅)C(O)NO˙^?, as a one-electron oxidation product, as well as N₂O as a final product. Successive UV–vis spectra of mixtures containing [Fe(CN)₅NH₃]^2? (though not [Fe(CN)₆]^3?) at pH 11 and 7 revealed an intermediate acylnitroso-complex, [Fe(CN)₅NOC(O)(C₆H₅)]^3? (λ_max, 465 nm, very stable at pH 7), formed through ligand interchange in the initially formed reduction product, [Fe(CN)₅NH₃]^3?, and characterized by FTIR spectra through the stretching vibrations ν_(CN), ν_(CO), and ν_(NO). Free acylnitroso derivatives, formed by alternative reaction paths of the hydroxamate radicals, hydrolyze forming RC(O)OH and HNO, postulated as precursor of N₂O. Minor quantities of NO are formed only with an excess of oxidant. The intermediacy of HNO was confirmed through its identification as [Fe(CN)₅(HNO)]^3? (λ_max, 445 nm) as a result of hydrolysis of [Fe(CN)₅(NOC(O)(C₆H₅)]^3? at pH 11. The results demonstrate that hydroxamic acids behave predominantly as HNO donors.     

Kinetic and mechanism of pentacyanohydroxoferrate(III) formation from the reaction of [Fe2HPDTA(OH)2] with cyanide ions

Summary The kinetics and mechanism of exchange of HPDTA in [Fe₂HPDTA(OH)₂] with cyanide ion (HPDTA=2-hydroxytrimethylenediaminetetraacetic acid) was investigated spectrophotometrically by monitoring the peak at 395 nm ( _max of [Fe(CN)₅OH]^3– at pH=11.0±0.02,I=0.25m (NaClO₄) at ±0.1°C).Three distinct observable stages were identified; the first is the formation of [Fe(CN)₅OH]^3–, the second the formation of [Fe(CN)₆]^3– from it and the third the reduction of [Fe(CN)₆]^3– to [Fe(CN)₆]^4– by HPDTA^4– released in the first stage.The first stage follows first-order kinetics in [Fe₂HPDTA(OH)₂] and second-order in [CN^–] over a wide range of [CN^–], but becomes zero order at [CN^–]<5×10^–2 m. We suggest a cyanide-independent dissociation of [Fe₂HPDTA)(OH)₂] into [FeHPDTA(OH)] and [Fe(OH)]²⁺ at low cyanide concentrations and a cyanide-assisted rapid dissociation of [Fe₂HPDTA(OH)₂] to [FeHPDTA(OH)(CN)]^3– and [Fe(OH)]²⁺ at higher cyanide concentrations. The excess of cyanide reacts further with [FeHPDTA(OH)(CN)]^3– finally to form [Fe(CN)₅OH]^3–.The reverse reaction between [Fe(CN)₅OH]^3– and HPDTA^4– is first-order in [Fe(CN)₅OH]^3– and HPDTA^4–, and exhibits inverse first-order dependence on cyanide concentration.A six-step mechanism is proposed for the first stage of reaction, with the fifth step as rate determining.     

Syntheses,characterization, and crystal structures of ruthenium(II)/(III) complexes with tridentate salicylaldiminato ligands

Treatment of [Ru(PPh₃)₃Cl₂] with one equivalent of tridentate Schiff base 2-[(2-dimethylamino-ethylimino)-methyl]-phenol (HL) in the presence of triethylamine afforded a ruthenium(III) complex [RuCl₃(κ²-N,N-NH₂CH₂CH₂NMe₂)(PPh₃)] as a result of decomposition of HL. Interaction of HL and one equivalent of [RuHCl(CO)(PPh₃)₃], [Ru(CO)₂Cl₂] or [Ru(tht)₄Cl₂] (tht = tetrahydrothiophene) under different conditions led to isolation of the corresponding ruthenium(II) complexes [RuCl(κ³-N,N,O-L)(CO)(PPh₃)] (2), [RuCl(κ³-N,N,O-L)(CO)₂] (3), and a ruthenium(III) complex [RuCl₂(κ³-N,N,O-L)(tht)] (4), respectively. Molecular structures of 1·CH₂Cl₂, 2·CH₂Cl₂, 3 and 4 have been determined by single-crystal X-ray diffraction.     

Crystal structure and magnetic properties of a three-dimensional complex constructed from [CuL]2+ and [Fe(CN)6]3− precursors

Self-assembly of the precursor [Cu(L)]²⁺ (L = 3,10-dipropyl-1,3,5,8,10,12-hexaazacyclotetradecane) with hexacyanometalate [Fe(CN)₆]³⁻ produces a 3-D cyano-bridged Cu(II)–Fe(III) bimetallic assembly, [CuL]₂[Fe(CN)₆]ClO₄ · H₂O (1), characterized by single-crystal X-ray diffraction studies, and magnetic measurements. The crystallographic determination reveals that each hexacyanoferromate(III) ion connects four copper(II) ions using four co-planar CN⁻ groups which axially coordinate to the copper ion in a trans fashion forming trans-CuL(N≡C)₂ moieties in (1). Magnetic studies reveal that (1) displays a ferromagnetic interaction between Cu(II) and Fe(III) through the CN linkage.     

Kristallstrukturen der Terpyridin-Komplexe [Cd(terpy)Cl2], [Cu(terpy)(CN)Cl] und [Cu(terpy)][Cu(CN)3] · H2O

Crystal Structures of the Terpyridine Complexes [Cd(terpy)Cl₂], [Cu(terpy)(CN)Cl], and [Cu(terpy)][Cu(CN)₃] · H₂O By reaction of cadmium chloride with 2,2′ : 6′,2″-terpyridine (“terpy”) in water/acetone crystals of [Cd(terpy)Cl₂] ( 1) were formed. The compound crystallizes monoclinic, space group P2₁/c, a = 1111.70(10), b = 823.10(7), c = 1643.00(14) pm, β = 93.913(1)°, Z = 4. Starting from mixtures of different molar ratios of copper(II) chloride, terpyridine, and KCN in water/methanole, two complexes of different composition were obtained. At the molar ratio of 1 : 1 : 2 a copper(II) coordination compound with both halide and pseudohalide ligands, [Cu(terpy)(CN)Cl] ( 2 ), was formed which also crystallizes monoclinic, P2₁/c, a = 1065.6(3), b = 824.6(2), c = 1644.5(7) pm, β = 98.214(3)°, Z = 4. At a molar ratio of 1 : 1 : 10 a partial reduction of copper(II) occured with formation of a mixed valency compound [Cu(terpy)][Cu(CN)₃] · H₂O ( 3 ) which crystallizes in the hexagonal space group P6₅22, with a = b = 800.29(1), c = 4771.05(7) pm, Z = 6. Compounds 1 and 2 are structurally similar, the coordination of the metal atoms is square pyramidal. Networks are formed by hydrogen bridges. In 3 the copper(II) ions show a distorted square planar coordination by the three N atoms of the terpy ligand and one N atom of a bridging CN^– group, the copper(I) atoms, however, show trigonal planar coordination by three CN^– ligands to which the water molecules are bonded by hydrogen bridges. Thus helical chains are formed which stretch in the direction of the screw axes. The EPR spectrum of 3 was measured.     

Coordination of RuCl3(NO)(H2O)2 by imidazole,histidine and iminodiacetate ligands: a study of complexation of 'Caged NO' by simple bio-cellular donors

The 'caged NO' reagent, RuCl₃NO(H₂O)₂, has been studied by n.m.r. and i.r. methods with imidazole, histidine, histamine, and N-methyliminodiacetate as complexing ligands. These ligands are representative of cellular donors that would be encountered as RuCl₃NO(H₂O)₂ migrates through biological cells. [RuCl₃NO(imH)(H₂O)], [RuCl₃(NO)(imH)₂] and [RuCl₂(NO)(imH)₃]⁺ complexes (imH = imidazole) have been detected by ¹H-n.m.r. and i.r. and electrospray mass spectrometry (e.s.i.–m.s.) methods. Based upon the effect of cis ligand addition on the (NO) frequency causing a decrease in frequency, the 1:1 and 1:2 complexes have the imidazole donors in the plane cis to the NO⁺ moiety, whereas the 1:3 species has the third imidazole trans to the NO⁺. The trans imidazole donor causes 'trans-strengthening' of the N–O bond of the {RuNO}⁶ chromophore. ¹H-n.m.r. shows that the monodentate imidazole donor(s) is (are) in rapid exchange with free imidazole in solution for each of the n = 1–3 species. Histidine and histamine make kinetically more stable 1:1 complexes with the major isomer having an axially-coordinated histidine imidazole donor, but in-plane donation for histamine. The carboxylate of coordinated histidine remains pendant according to i.r. and ¹³C-n.m.r. data. From syntheses carried out at pH ca. 5, the amino donor is H-bonded to an in-plane H₂O in the major species (ca. 75%) and coordinated with displacement of the in-plane H₂O in the lesser isomer (25%). By contrast, the histamine ligand binds with an in-plane bound imidazole and a pendant protonated amino group (94%). The remaining 6% has an in-plane chelated histamine, analogous to the bis imidazole species and the known fac, cis-[RuCl₃NO(en)] complex. N-Methyliminodiacetate is observed to form one main [RuCl(NO)(mida)(H₂O)] complex (85%) with two chelated glycinato donor groups with RuCl₃NO(H₂O)₂, one glycinato group chelated 'in-plane' with the central amine donor and one axial coordinated glycinato donor. A second [RuCl(NO)(mida)(H₂O)] complex (the remaining 15%) has the amine donor trans to NO⁺ and chelated glycinato groups which coordinate in the RuClO₂(OH₂) plane, either cis or trans to each other, in a 60:40 split (ca. 9% and 6%). The presence of one Cl^– and one H₂O in the [RuCl(NO)(mida)(H₂O)] complexes was established by e.s.i.–m.s. These results show that RuCl₃NO(H₂O)₂ is likely to be freely mobile within a cellular environment, forming stable complexes via bidentate chelation with 'two-point' nitrogen donors (en, his, etc).     

[Ni(terpy)(H2O)]‐trans‐[Ni‐(μ‐CN)2‐(CN)2]n,a one‐dimensional linear tetra­cyano­nickelate chain

The one‐dimensional chain catena‐poly­[[aqua(2,2′:6′,2′′‐terpyridyl‐κ³N)­nickel(II)]‐μ‐cyano‐κ²N:C‐[bis­(cyano‐κC)nickelate(II)]‐μ‐cyano‐κ²C:N], [Ni(terpy)(H₂O)]‐trans‐[Ni‐μ‐(CN)₂‐(CN)₂]_n or [Ni₂­(CN)₄­(C₁₅H₁₁N₃)(H₂O)], consists of infinite linear chains along the crystallographic [10] direction. The chains are composed of two distinct types of nickel ions, paramagnetic octahedral [Ni(terpy)(H₂O)]²⁺ cations (with twofold crystallographic symmetry) and diamagnetic planar [Ni(CN)₄]^2? anions (with the Ni atom on an inversion center). The [Ni(CN)₄]^2? units act as bidentate ligands bridging through two trans cyano groups thus giving rise to a new example of a trans–trans chain among planar tetra­cyano­nickelate complexes. The coordination geometry of the planar nickel unit is typical of slightly distorted octahedral nickel(II) complexes, but for the [Ni(CN)₄]^2? units, the geometry deviates from a planar configuration due to steric interactions with the ter­pyridine ligands.     

Synthesis,characterization and anticancer activity of 3-aminopyrazine-2-carboxylic acid transition metal complexes

Synthetic procedures are described that allow access to the new complexes cis-[Mo₂O₅(apc)₂], cis-[WO₂(apc)₂], trans-[UO₂(apc)₂], [Ru(apc)₂(H₂O)₂], [Ru(PPh₃)₂(apc)₂], [Rh(apc)₃], [Rh(PPh₃)₂(apc)₂]ClO₄, [M(apc)₂], [M(PPh₃)₂(apc)]Cl, [M(bpy)(apc)]Cl (M(II) = Pd, Pt), [Pd(bpy)(apc)Cl], [Ag(apc)(H₂O)₂] and [Ir(bpy)(Hapc)₂]Cl₃, where Hapc, is 3-aminopyrazine-2-carboxylic acid. These complexes were characterized by physico-chemical and spectroscopic techniques. Both Hapc and several of its complexes display significant anticancer activity against Ehrlich ascites tumour cells (EAC) in albino mice.     

Phosphaniminato-Komplexe des Antimons. Die Kristallstrukturen von [Sb2Cl5(NPMe3)2][SbCl6] · CH3CN und [SbCl(NPPh3)]2[SbCl6]2 · 6 CH3CN

Phosphorane Iminato Complexes of Antimony. The Crystal Structures of [Sb₂Cl₅(NPMe₃)₂][SbCl₆] · CH₃CN and [SbCl(NPPh₃)]₂[SbCl₆]₂ · 6 CH₃CN The title compounds are formed by reaction of antimony pentachloride in acetonitrile solution with the phosphorane iminato complexes SbCl₂(NPMe₃) and SbCl₂(NPPh₃), respectively, which themselves are synthesized by reaction of antimony trichloride with Me₃SiNPR₃ (R = Me, Ph). The complexionic compounds are characterized by ¹²¹Sb Mössbauer spectroscopy and by crystal structure determinations. [Sb₂Cl₅(NPMe₃)₂][SbCl₆] · CH₃CN: Space group P4₁, Z = 4, 3 698 observed unique reflections, R = 0.022. Lattice dimensions at ?60°C: a = b = 1 056.0(1), c = 2 709.6(2) pm. The structure consists of SbCl₆^? ions and cations [Sb₂Cl₅(NPMe₃)₂(CH₃CN)]⁺, in which one Sb^III atom and one Sb^V atom are bridged by the N atoms of the phosphorane iminato ligands. [SbCl(NPPh₃)]₂[SbCl₆]₂ · 6 CH₃CN: Space group P1 , Z = 2, 5 958 observed unique reflections, R = 0.033. Lattice dimensions at ?60°C: a = 989.4(11), b = 1 273(1), c = 1 396(1) pm, α = 78.33(7), β = 77.27(8)°, γ = 86.62(8)°. The structure consists of SbCl₆^? ions and centrosymmetric cations [SbCl(NPPh₃)(CH₃CN)₂]₂²⁺, in which the antimony atoms are bridged by the N atoms of the phosphorane iminato ligands.     

Preparation and Characterization of Dinuclear Chromium(III) Complexes of a Hexadentate Tetraaza‐Dithiophenolate Ligand

The ability of the tetraaza‐dithiophenolate ligand H₂L² (H₂L² = N,N′‐Bis‐[2‐thio‐3‐aminomethyl‐5‐tert‐butyl‐benzyl]propane‐1,3‐diamine) to form dinuclear chromium(III) complexes has been examined. Reaction of Cr^IICl₂ with H₂L² in methanol in the presence of base followed by air‐oxidation afforded cis,cis‐[(L²)Cr^III₂(μ‐OH)(Cl)₂]⁺ ( 1a ) and trans,trans‐[(L²)Cr^III₂(μ‐OH)(Cl)₂]⁺ ( 1b ). Both compounds contain a confacial bioctahedral N₂ClCr^III(μ‐SR)₂(μ‐OH)Cr^IIIClN₂ core. The isomers differ in the mutual orientation of the coligands and the conformation of the supporting ligand. In 1a both Cl^? ligands are cis to the bridging OH function. In 1b they are in trans‐positions. Reaction of the hydroxo‐bridged complexes with HCl yielded the chloro‐bridged cations cis,cis‐[(L²)Cr^III₂(μ‐Cl)(Cl)₂]⁺ ( 2a ) and trans,trans‐[(L²)Cr^III₂(μ‐Cl)(Cl)₂]Cl ( 2b ), respectively. These bridge substitutions proceed with retention of the structures of the parent complexes 1a and 1b .     

Synthesis,characterization and antineoplastic activity of 5-chloro-2,3-dihydroxypyridine transition metal complexes

Synthetic procedures are described that allow access to cis-[Mo₂O₅(cdhp)₂]^2?, cis-[W₂O₅(Hcdhp)₂], trans-[OsO₂(cdhp)₂]^2?, trans-[UO₂(Hcdhp)₂], [ReO(PPh₃)(Hcdhp)₂]X (X =?Cl, I), [ReO₂(cdhp)₂]^?, [M(PPh₃)₂(cdhp)], [M(bpy)(cdhp)] (M(II) =?Pd, Pt), [Ru(YPh₃)₂(Hcdhp)₂] (Y =?P, As), [Rh(Hcdhp)₂Cl(H₂O)], [Rh(PPh₃)₂(Hcdhp)₂]ClO₄ and [Ir(bpy)(cdhp)Cl₂], where Hcdhp, cdhp are the deprotonated monoanion of 5-chloro-3-hydroxypyrid-2-one and dianion of 5-chloro-2,3-dihydroxypyridine, respectively. These complexes were characterized by their Raman, IR, ¹H NMR, electronic and mass spectra, conductivity, magnetic and thermal measurements. H₂cdhp, cis-K₂[Mo₂O₅(cdhp)₂], [Pd(bpy)(cdhp)] display a significant antineoplastic activity against Ehrlich ascites tumor cells (EAC).     

Reductive nitrosylation of tetraoxometallates. part V1. single pot and A virtually single step synthesis of chromium(l) cyanonitrosyl derivatives directly from chromate(VI) in aqueous-aerobic media.

Cyanonitrosyl complexes and their derivatives of the types [Cr(NO)(CN)₄]^2?, [Cr(NO)(CN)₃H₂O]^? and [Cr(NO)(CN)₂ LL] [LL = 2,2′ bipyridine (bipy) or 1, 10-Phenanthroline (phen)] are synthesised directly from CrO₄^2? using NH₂OH.HCl, OH^? and CN^? and other appropriate ligands, virtually in a single step process in an aqueous aerobic medium. The compounds are characterised by IR, molar conductance, magnetic susceptibility, e.s.r, electronic spectra and thermoanalytical data.     

NO donors cis-[Ru(bpy)2(L)NO] and [Fe(CN)4(L)NO] complexes immobilized on modified mesoporous silica spheres

The reaction of [Ru(bpy)₂Cl₂] and Na₂[Fe(CN)₄(dmso)₂] complexes with isonicotinic acid immobilized on silica spheres (Si-ATPS-ISN) followed by a NO bubbling produced Si-ATPS-ISN-[Ru(bpy)₂(NO)] (system I) and Si-ATPS-ISN-[Fe(CN)₄(NO)] (system II). The characterization of these systems was carried out by UV–Vis, FTIR spectroscopy and electrochemical techniques. As judged by the FTIR data, the nitric oxide ligand has an NO⁺ character in both systems (ν(NO⁺): 1938 cm⁻¹). The NO release, which was monitored by means of FTIR, electrochemistry, and NO sensor electrode, was observed for both systems upon white light irradiation and chemical reduction by cysteine. These results indicated that the system (II) presents a higher potential for controlled NO release. The characterization (FTIR and UV–Vis) of the systems after the NO release suggested the formation of the aqua systems ATPS-ISN-[Ru(bpy)₂(OH₂)] and ATPS-ISN-[Ru(bpy)₂(OH₂)].     

Palladium(II) Complexes of 1-vinylimidazole

Two new co-ordination compounds of Pd^II with 1-vinylimidazole of the formulae [PdL₄]Cl₂·3H₂O and trans-[PdL₂Cl₂], where L is a 1-vinylimidazole molecule, have been obtained. The compounds were characterised by spectroscopic, molar conductivity, thermogravimetric and magnetochemical measurements. Single crystal X-ray structure analyses of the complexes were also carried out. The compounds are diamagnetic with square-planar coordinatination around the palladium(II) ions. Other physico-chemical properties of the both complexes are compatible with their structures.     

Die Kristallstrukturen der Hexachlorometallate NH4[SbCl6], NH4[WCl6], [K(18‐Krone‐6)(CH2Cl2)]2[WCl6]·6CH2Cl2 und (PPh4)2[WCl6]·4CH3CN

Crystal Structures of the Hexachlorometalates NH₄[SbCl₆], NH₄[WCl₆], [K(18‐crown‐6)(CH₂Cl₂)]₂[WCl₆]·6CH₂Cl₂ and (PPh₄)₂[WCl₆]·4CH₃CN The crystal structures of the title compounds were determined by single crystal X‐ray methods. NH₄[SbCl₆] and NH₄[WCl₆] crystallize isotypically in the space group C2/c with four formula units per unit cell. The NH₄⁺ ions occupy a twofold crystallographic axis, whereas the metal atoms of the [MCl₆]^— ions occupy a centre of inversion. There exist weak interionic hydrogen bridges. [K(18‐crown‐6)(CH₂Cl₂)]₂[WCl₆]·6CH₂Cl₂ crystallizes in the orthorhombic space group R3¯/m with Z = 3. The compound forms centrosymmetric ion triples, in which the potassium ions are coordinated with a WCl₃ face each. In trans‐position to it the chlorine atom of a CH₂Cl₂ molecule is coordinated so that, together with the oxygen atoms of the crown ether, coordination number 10 is achieved. (PPh₄)₂[WCl₆]·4CH₃CN crystallizes in the monoclinic space group P2₁/c with Z = 4. This compound, too, forms centrosymmetric ion triples, in which in addition the acetonitrile molecules are connected with the [WCl₆]^2— ion via weak C—H···Cl contacts.     

catena‐Poly­[[[1,8‐bis(2‐hydroxy­ethyl)‐1,3,6,8,10,13‐hexa­aza­cyclo­tetra­decane]copper(II)]‐μ‐cyano‐[tri­cyano­nitro­soiron(III)]‐μ‐cyano]

The bimetallic title complex, [CuFe(CN)₅(C₁₂H₃₀N₆O₂)(NO)] or [Cu(L)Fe(CN)₅(NO)] [where L is 1,8‐bis(2‐hydroxy­ethyl)‐1,3,6,8,10,13‐hexa­aza­cyclo­tetra­decane], has a one‐dimensional zigzag polymeric –Cu(L)–NC–Fe(NO)(CN)₃–CN–Cu(L)– chain, in which the Cu^II and Fe^II centres are linked by two CN groups. In the complex, the Cu^II ion is coordinated by four N atoms from the L ligand [Cu—N(L) = 1.999 (2)–2.016 (2) Å] and two cyanide N atoms [Cu—N = 2.383 (2) and 2.902 (3) Å], and has an elongated octahedral geometry. The Fe^II centre is in a distorted octahedral environment, with Fe—N(nitroso) = 1.656 (2) Å and Fe—C(CN) = 1.938 (3)–1.948 (3) Å. The one‐dimensional zigzag chains are linked to form a three‐dimensional network via N—H⋯N and O—H⋯N hydrogen bonds.     

Syntheses,crystal structures and magnetic properties of two cyano-bridged two-dimensional assemblies [Fe(salpn)]2 [Fe(CN)5NO] and [Fe(salpn)]2[Ni(CN)4]

Two cyano-bridged assemblies, [Fe^III(salpn)]₂[Fe^II(CN)₅NO] (1) and [Fe^III (salpn)]₂[Ni^II(CN)₄] (2) [salpn = N, N-1,2-propylenebis(salicylideneiminato)dianion], have been prepared and structurally and magnetically characterized. In each complex, [Fe(CN)₅NO]^2– or [Ni(CN)₄]^2– coordinates with four [Fe(salpn)]⁺ cations using four co-planar CN^– ligands, whereas each [Fe(salpn)]⁺ links two [Fe(CN)₅NO]^2– or [Ni(CN)₄]^2– ions in the trans form, which results in a two-dimensional (2D) network consisting of pillow-like octanuclear [—M^II—CN—Fe^III—NC—]₄ units (M = Fe or Ni). In complex (1), the NO group of [Fe(CN)₅NO]^2– remains monodentate and the bond angle of Fe^II—N—O is 180.0°. The variable temperature magnetic susceptibilities, measured in the 5–300 K range, show weak intralayer antiferromagnetic interactions in both complexes with the intramolecular iron(III)iron(III) exchange integrals of –0.017 cm^–1 for (1) and –0.020 cm^–1 for (2), respectively.